CRISCuris, Inc.

$15M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-6.6% YoY

Gross Profit

$3M98.0% margin

Operating Income

-$12M-452.5% margin

Net Income

-$12M-434.4% margin

EPS (Diluted)

$-2.04

QoQ Revenue Growth

-4.8%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$77M

Total Liabilities

$58M

Stockholders' Equity

$20M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-6.6%
Gross Profit	$3M	$3M	-6.2%
Operating Income	-$12M	-$10M	-19.4%
Net Income	-$12M	-$11M	-3.4%

Revenue Segments

Gross Royalty Revenue

$3M100%

CRIS Q4 2023 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena